K. Vonck et al., Acute single photon emission computed tomographic study of vagus nerve stimulation in refractory epilepsy, EPILEPSIA, 41(5), 2000, pp. 601-609
Purpose: Left-sided vagus nerve stimulation (VNS) is an efficacious treatme
nt for patients with refractory epilepsy. The precise mechanism of action r
emains to be elucidated. Only limited data on VNS-induced changes in region
al cerebral blood flow (rCBF) are available. The aim of this study was to i
nvestigate rCBF changes during initial VNS with single-photon emission comp
uted tomography (SPECT).
Methods: In 12 patients (8 women, 4 men) with mean age of 32 years and mean
duration of epilepsy of 19 years, VNS-induced rCBF changes were studied by
means of a Tc-99m-ethyl cysteinate dimer activation study with a single-da
y split-dose protocol before and immediately after initial stimulation. Ima
ges were acquired on a triple-head camera with fan-beam collimators and wer
e reconstructed with scatter and attenuation correction. After coregistrati
on to a standardized template, both a semiquantitative analysis using prede
fined volumes-of-interest (VOIs) as well as voxel-by-voxel analysis of the
intra-subject activation were performed. During follow-up, efficacy of VNS
in terms of seizure-frequency reduction was studied.
Results: The semiquantitative analysis, with reference to the total counts
in all VOIs, revealed a significant decrease of activity in the left thalam
us immediately after the initial stimulation train. These results agreed wi
th voxel-by-voxel analysis. In our study ipsilateral thalamic hypoperfusion
was the most significant finding. Mean frequency of complex partial seizur
es was reduced from 30 per month before implantation to six per month after
implantation.
Conclusions: VNS induces rCBF changes immediately after initial stimulation
that can be studied with SPECT. VNS-induced changes in the thalamus may pl
ay an important role in suppression of seizures. However, no significant re
lation between the level of hypoperfusion and subsequent clinical efficacy
was found.